Just as when LASIK was first approved in 1995, the FDA approval of Wavefront-guided CustomVue LASIK was initially for nearsighted individuals. Nearsighted individuals with up to -6 diopters or refractive error and/or astigmatism between 0 and 3 diopters may qualify for wavefront.

Now, farsighted individuals and those with mixed astigmatism may qualify for CustomVue wavefront, too.

Wavefront candidacy is still guided by physician review and interpretation of one' higher order aberration. Prevailing wisdom is patients with higher order aberrations that make up 20 percent of the total aberrations of the eye make better custom Wavefront LASIK patients.

CustomVue wavefront patients must be at least 21 years of age or older and have a stable manifest refraction (no more than 0.5 diopter change for the previous year).
It is not recommended for patients with collagen vascular, auto-immune or immunodeficiency diseases; women who are pregnant or nursing; signs of keratoconus or abnormal corneal topography or are taking Accutane or Cordarone medications.

Other conditions that may affect candidacy include diabetes, history of Herpes simplex or Herpes zoster keratitis; significant dry eye that is unresponsive to treatment, and severe allergies.

CLICK HERE to schedule your FREE CONSULTATION